Skip to main content

Table 5 Demographic characteristics of BuZhongYiQiTang use among patients with Alzheimer’s disease

From: Patterns of Chinese medicine use in prescriptions for treating Alzheimer’s disease in Taiwan

Characteristics BuZhongYiQiTang users (%) CMa users not using BuZhongYiQiTang (%) aORb (95 % CIc)
No. of cases 685 (77.1) 204 (22.9)  
Age at diagnosis
 <45 5 (0.7) 2 (1) 0.69 (0.12–6.03)
 45–54 21 (3.1) 2 (1) 3.17 (0.70–17.44)
 55–64 88 (12.8) 22 (10.8) 1
 65–74 221 (32.1) 70 (34.3) 0.72 (0.23–1.34)
 75–84 304 (44.1) 92 (45.1) 0.92 (0.41–1.52)
 ≥85 45 (6.5) 16 (7.8) 0.64 (0.22–1.59)
Sex
 Female 377 (55.0) 99 (48.5) 1.23 (1.04–1.57)
 Male 308 (45.0) 104 (51.0) 1
Numbers of anti–Alzheimer’s or BPSD drugs
 1 26 (3.8) 11 (5.4) 1
 2 133 (19.4) 55 (27.0) 0.82 (0.21–2.01)
 3 259 (37.8) 75 (36.8) 1.32 (0.52–2.81)
 ≥4 367 (39.0) 63 (40.9) 1.04 (0.57–2.11)
Numbers of dementia BPSDd
 0 84 (12.3) 42 (20.6) 1
 1 115 (16.8) 63 (30.9) 0.72 (0.31–1.68)
 2 206 (30.1) 52 (25.5) 2.11 (0.93–3.38)
 ≥3 280 (40.9) 63 (30.9) 2.75 (0.82–4.31)
Numbers of comorbidity
 0 22 (3.2) 12 (5.9) 1
 1 90 (13.1) 35 (17.2) 1.21 (0.38–3.71)
 2 119 (17.4) 57 (27.9) 1.02 (0.31–4.23)
 ≥3 454 (66.3) 99 (48.5) 2.24 (0.71–4.55)
  1. a CM refers to traditional Chinese medicine
  2. b aOR refers to adjust odds ratio
  3. c CI refers to confidence interval
  4. d BPSD refers to behavioral and psychological symptoms of dementia